Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Pivotal bioVenture Partners Fund I, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 SC 13D/A Pivotal bioVenture Partners Fund I, L.P. reports a 9.5% stake in Inozyme Pharma, Inc.
08/03/2023 4 Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 119,048 shares @ $4.8, valued at $571.4k
Bought 714,285 shares @ $4.8, valued at $3.4M
05/23/2023 SC 13D/A Pivotal bioVenture Partners Fund I, L.P. reports a 8.3% stake in Inozyme Pharma, Inc.
04/04/2023 SC 13D/A Pivotal bioVenture Partners Fund I, L.P. reports a 7.4% stake in Inozyme Pharma, Inc.
03/15/2023 SC 13G Pivotal bioVenture Partners Fund I, L.P. reports a 9.3% stake in Oculis Holding AG
08/25/2022 SC 13G/A Pivotal bioVenture Partners Fund I, L.P. reports a 4.9% stake in Akouos, Inc.
04/28/2022 SC 13D Pivotal bioVenture Partners Fund I, L.P. reports a 6.6% stake in Inozyme Pharma, Inc.
04/20/2022 4 Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 1,070,000 shares @ $3.69, valued at $3.9M
02/14/2022 SC 13G/A Pivotal bioVenture Partners Fund I, L.P. reports a 6.7% stake in Inozyme Pharma, Inc.
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/13/2021 SC 13D/A Pivotal bioVenture Partners Fund I, L.P. reports a 8.4% stake in Bolt Biotherapeutics, Inc.
08/12/2021 SC 13D Pivotal bioVenture Partners Fund I, L.P. reports a 7.3% stake in Rallybio Corporation
02/17/2021 SC 13D Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Bolt Biotherapeutics, Inc.
02/09/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/04/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/10/2020 SC 13D Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Akouos, Inc.
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/02/2018 4 Pivotal bioVenture Partners Fund I, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Converted 359,267 shares @ $0
Converted 458,425 shares @ $0
Bought 337,724 shares @ $15, valued at $5.1M
Converted 7,446,904 options to buy @ $0
Converted 9,502,249 options to buy @ $0
09/25/2018 3 Pivotal bioVenture Partners Fund I, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc.
03/29/2018 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
03/29/2017 D/A Form D/A - Notice of Exempt Offering of Securities [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy